Cytotoxicity of herbal extracts used for treatment of prostatic disease on head and neck carcinoma cell lines and non-malignant primary mucosal cells

Schmidt,Marianne; Polednik,Christine; Roller,Jeanette; Hagen,Rudolf

doi:10.3892/or.2012.2145

Cytotoxicity of herbal extracts used for treatment of prostatic disease on head and neck carcinoma cell lines and non-malignant primary mucosal cells

Authors:
- Marianne Schmidt
- Christine Polednik
- Jeanette Roller
- Rudolf Hagen
View Affiliations

Affiliations: Department of Otorhinolaryngology, University of Wuerzburg, D-97080 Würzburg, Germany
Published online on: November 19, 2012 https://doi.org/10.3892/or.2012.2145
Pages: 628-636

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previously, a growth inhibiting effect of PC-Spes on head and neck carcinoma cell lines had been demonstrated. In order to determine the toxic impact of particular herbs in the mixture, we exposed the head and neck cancer cell lines FADU, HLaC79 and its Paclitaxel-resistant subline HLaC79-Clone1 as well as primary mucosal keratinocytes to increasing concentrations of the herbal mixture Prostaprotect, which has a similar formulation as PC-Spes, as well as its single herbal components Dendranthema morifolium, Ganoderma lucidium, Glycyrrhiza glabra, Isatis indigotica, Panax pseudo-ginseng, Rabdosia rubescens, Scutellaria baicalensis and Pygeum africanum. Growth inhibition was measured using the MTT assay. Expression of P-glycoprotein (P-GP), multidrug resistance protein-1 (MRP-1), multidrug resistance protein-2 (MRP-2), breast cancer resistance protein (BCRP) and androgen receptor (AR) were examined by western blot analysis. Pygeum africanum extract clearly turned out as the main cytotoxic component of the Prostaprotect prescription mixture, and initated apoptosis in sensitive cell lines. All other extracts had only minor toxic effects. Western blot analysis revealed increased expression of P-GP in HLaC79-Clone1 cells, while HLaC79 and FADU cells were negative. All three cell lines were negative for MRP-1 and BCRP but positive for MRP-2. HLaC79 and its descendant HLaC79-Clone1 both expressed AR, as verified by western blotting and immunofluorescence staining. Primary mucosal keratinocytes were negative for all multidrug resistance markers as well as for AR. Growth inhibition rates of the single herbal extracts were compared with previously published results in prostate carcinoma cell lines. The relationship between expression levels of AR and multidrug resistance markers in relation to the measured toxicity of herbal extracts in our head and neck cancer cell system is critically discussed.

View Figures

View References

1	Schmidt M, Polednik C, Gruensfelder P, Roller J and Hagen R: The effects of PC-Spes on chemosensitive and chemoresistant head and neck cancer cells and primary mucosal keratinocytes. Oncol Rep. 21:1297–1305. 2009. View Article : Google Scholar : PubMed/NCBI
2	DiPaola RS, Zhang H, Lambert GH, Meeker R, Licitra E, Rafi MM, Zhu BT, Spaulding H, Goodin S, Toledano MB, Hait WN and Gallo MA: Clinical and biologic activity of an estrogenic herbal combination (PC-Spes) in prostate cancer. N Engl J Med. 339:785–791. 1998. View Article : Google Scholar : PubMed/NCBI
3	De la Taille A, Buttyan R, Hayek O, Bagiella E, Shabsigh A, Burchardt M, Burchardt T, Chopin DK and Katz AE: Herbal therapy PC-Spes: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer. J Urol. 164:1229–1234. 2000.PubMed/NCBI
4	Moyad MA, Pienta KJ and Montie JE: Use of PC-Spes, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease. Urology. 54:319–324. 1999. View Article : Google Scholar : PubMed/NCBI
5	Small EJ, Frohlich MW, Bok R, Shinohara K, Grossfeld G, Rozenblat Z, Kelly WK, Corry M and Reese DM: Prospective trial of the herbal supplement PC-Spes in patients with progressive prostate cancer. J Clin Oncol. 18:3595–3603. 2000.PubMed/NCBI
6	Dedhia RC and McVary KT: Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 179:2119–2125. 2008. View Article : Google Scholar : PubMed/NCBI
7	Shenouda NS, Sakla MS, Newton LG, et al: Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo. Endocrine. 31:72–81. 2007.
8	Pierini N, Citti F, Di Marzio S, Pozzato C and Quercia V: Identification and determination of N-docosanol in the bark extract of Pygeum africanum and in patent medicines containing it. Boll Chim Farm. 121:27–34. 1982.(In Italian).
9	Roell D and Baniahmad A: The natural compounds atraric acid and N-butylbenzene-sulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growth. Mol Cell Endocrinol. 332:1–8. 2011. View Article : Google Scholar
10	Pfreundner L, Hoppe F, Willner J, Preisler V, Bratengeier K, Hagen R, Helms J and Flentje M: Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas - a possibility for organ preservation. Radiother Oncol. 68:163–170. 2003. View Article : Google Scholar
11	Zenner HP, Lehner W and Herrmann IF: Establishment of carcinoma cell lines from larynx and submandibular gland. Arch Otorhinolaryngol. 225:269–277. 1979. View Article : Google Scholar : PubMed/NCBI
12	Imaizumi F, Asahina I, Moriyama T, Ishii M and Omura K: Cultured mucosal cell sheet with a double layer of keratinocytes and fibroblasts on a collagen membrane. Tissue Eng. 10:657–664. 2004. View Article : Google Scholar : PubMed/NCBI
13	Limtrakul P, Anuchapreeda S and Buddhasukh D: Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer. 4:132004. View Article : Google Scholar : PubMed/NCBI
14	Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275. 1951.PubMed/NCBI
15	Kyhse-Andersen J: Electroblotting of multiple gels: a simple apparatus without tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods. 10:203–210. 1984. View Article : Google Scholar : PubMed/NCBI
16	Yablonsky F, Nicolas V, Riffaud JP and Bellamy F: Antiproliferative effect of Pygeum africanum extract on rat prostatic fibroblasts. J Urol. 157:2381–2387. 1997.
17	Hsieh TC and Wu JM: Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells. Int J Oncol. 20:583–588. 2002.PubMed/NCBI
18	Kimura M, Inoue H, Hirabayashi K, Natsume H and Ogihara M: Glycyrrhizin and some analogues induce growth of primary cultured adult rat hepatocytes via epidermal growth factor receptors. Eur J Pharmacol. 431:151–161. 2001. View Article : Google Scholar : PubMed/NCBI
19	Grandis JR and Tweardy DJ: Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res. 53:3579–3584. 1993.PubMed/NCBI
20	Bianchini C, Pastore A, Pelucchi S, et al: Sex hormone receptor levels in laryngeal carcinoma: a comparison between protein and RNA evaluations. Eur Arch Otorhinolaryngol. 265:1089–1094. 2008. View Article : Google Scholar : PubMed/NCBI
21	Chen B, Wang J, Li W and Ji W: Expression of androgen receptor and estrogen receptor in carcinoma of larynx. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 20:649–651. 2006.(In Chinese).
22	Nehse G and Tunn S: Androgen and progesterone receptors in oral carcinoma. J Craniomaxillofac Surg. 22:114–119. 1994. View Article : Google Scholar : PubMed/NCBI
23	Fedoruk MN, Gimenez-Bonafe P, Guns ES, Mayer LD and Nelson CC: P-glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cells. Prostate. 59:77–90. 2004. View Article : Google Scholar : PubMed/NCBI
24	Izzo AA and Ernst E: Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 61:2163–2175. 2001. View Article : Google Scholar : PubMed/NCBI